Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

SOUTH SAN FRANCISCO, CA US

1. 20090293137 Novel Gene Disruptions, Compositions and Methods Relating Thereto 11-26-2009
2. 20090288176 Novel Gene Disruptions, Compositions and Methods Relating Thereto 11-19-2009
3. 20090286258 ANALYSIS OF ANTIBODY DRUG CONJUGATES BY BEAD-BASED AFFINITY CAPTURE AND MASS SPECTROMETRY 11-19-2009
4. 20090285837 HER2 ANTIBODY COMPOSITION - composition comprising a main species HER2 antibody that binds to domain II of HER2 and an amino acid sequence variant 11-19-2009
5. 20090285830 ANTIBODIES TO LYMPHOTOXIN-ALPHA - The invention provides various antibodies that bind to lymphotoxin 11-19-2009
6. 20090275659 Phenyl acetic acid derivatives as inflammation modulators 11-05-2009
7. 20090270595 IL-1 RELATED POLYPEPTIDES - novel polypeptides having homology to the IL-1-like family of proteins and to nucleic acid molecules encoding those 10-29-2009
8. 20090270473 DUAL-ACTING ANTIHYPERTENSIVE AGENTS - compounds having the formula: STR00001 wherein: Q W Y 10-29-2009
9. 20090269811 IL-1 RELATED POLYPEPTIDES - novel polypeptides having homology to the IL-1-like family of proteins and to nucleic acid molecules encoding those 10-29-2009
10. 20090269351 METHOD OF DIAGNOSING AND TREATING GLIOMA 10-29-2009
11. 20090269339 RESPONSES TO IMMUNIZATIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH A CD20 ANTIBODY 10-29-2009
12. 20090269338 HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF 10-29-2009
13. 20090264370 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 10-22-2009
14. 20090258025 TREATMENTS AND DIAGNOSTICS FOR CANCER, INFLAMMATORY DISORDERS AND AUTOIMMUNE DISORDERS 10-15-2009
15. 20090258013 NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES 10-15-2009
16. 20090247627 AMINO- AND AMIDO-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS 10-01-2009
17. 20090246173 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-01-2009
18. 20090239904 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY 09-24-2009
19. 20090239236 GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY 09-24-2009
20. 20090226465 MACROCYCLIC DEPSIPEPTIDE ANTIBODY-DRUG CONJUGATES AND METHODS 09-10-2009
21. 20090221638 CRYSTALLINE FORM OF A BIPHENYL COMPOUND - crystalline 1,2-ethanedisulfonic acid salt of biphenyl-2-ylcarbamic acid 1-[2--2-hydroxy-2 09-03-2009
22. 20090221630 IAP INHIBITORS - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have 09-03-2009
23. 20090221470 USE OF AN ECHINOCANDIN ANTIFUNGAL AGENT IN COMBINATION WITH A GLYCOPEPTIDE ANTIBACTERIAL AGENT 09-03-2009
24. 20090220504 COMBINATORIAL THERAPY - the use of VEGF antagonists and alpha5beta1 antagonists for treating cancer and inhibiting angiogenesis and/or vascular 09-03-2009
25. 20090215982 GLYCOPEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME 08-27-2009
26. 20090215803 Pyrimidinones as Casein Kinase II (CK2) Modulators 08-27-2009
27. 20090215674 USE OF A POLYENE MACROLIDE ANTIFUNGAL AGENT IN COMBINATION WITH A GLYCOPEPTIDE ANTIBACTERIAL AGENT 08-27-2009
28. 20090215673 PROCESS FOR PURIFYING GLYCOPEPTIDE PHOSPHONATE DERIVATIVES 08-27-2009
29. 20090214564 ANTI-EPHRINB2 ANTIBODIES AND METHODS USING SAME 08-27-2009
30. 20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same 08-20-2009
31. 20090209582 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists 08-20-2009
32. 20090208500 Method of producing antibodies with improved function 08-20-2009
33. 20090204489 BIOLOGICAL MARKERS PREDICTIVE OF RHEUMATOID ARTHRITIS RESPONSE TO B-CELL ANTAGONISTS 08-13-2009
34. 20090202546 COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF 08-13-2009
35. 20090202536 ANTIBODY-DRUG CONJUGATES AND METHODS - antibody-drug conjugate compounds of Formula I: Ab 08-13-2009
36. 20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto 08-06-2009
37. 20090192289 OMI PDZ MODULATORS - The invention provides modulators of Omi PDZ-ligand interaction, and methods of identifying and using these modulators 07-30-2009
38. 20090191215 Treatment with anti-VEGF Antibodies - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 07-30-2009
39. 20090191209 METHODS AND COMPOSITIONS FOR TARGETING POLYUBIQUITIN 07-30-2009
40. 20090191184 DcR3 polypeptide, A TNFR homolog - TNFR homolog, identified as DcR3, is provided 07-30-2009
41. 20090186812 Apo-2 ligand - novel cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is provided 07-23-2009
42. 20090186409 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR 07-23-2009
43. 20090186363 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR 07-23-2009
44. 20090186018 COMPOSITIONS AND METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS 07-23-2009
45. 20090181024 NOVEL COMPOSITION AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES 07-16-2009
46. 20090176833 DIALKYLPHENYL COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY 07-09-2009
47. 20090176822 PYRROLIDINE INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the 07-09-2009
48. 20090176774 Compounds and methods of use - Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases 07-09-2009
49. 20090176767 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 07-09-2009
50. 20090175865 CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES 07-09-2009
51. 20090175855 NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES 07-09-2009
52. 20090175854 Methods of using death receptor ligands and CD20 antibodies 07-09-2009
53. 20090170870 AMIDINE-CONTAINING COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 07-02-2009
54. 20090169569 APO-2L receptor agonist and CPT-11 synergism 07-02-2009
55. 20090169556 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 07-02-2009
56. 20090169550 THERAPY OF RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS PATIENTS 07-02-2009
57. 20090163471 Tropane compounds - compound according to Formula I or II: STR00001 wherein R 06-25-2009
58. 20090163419 Human growth hormone aqueous formulation 06-25-2009
59. 20090162364 Apo-2 ligand - novel cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is provided 06-25-2009
60. 20090155807 C-MET MUTATIONS IN LUNG CANCER - The invention provides methods and compositions useful for detecting mutations in c-met in lung cancer cells 06-18-2009
61. 20090155259 EXTENDING TIME TO DISEASE PROGRESSION OR SURVIVAL IN CANCER PATIENTS 06-18-2009
62. 20090155247 Methods of Using Death Receptor Agonists and EGFR Inhibitors 06-18-2009
63. 20090149535 3-CARBOXYPROPYL-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS 06-11-2009
64. 20090149521 DUAL-ACTING BENZOIMIDAZOLE ANTIHYPERTENSIVE AGENTS 06-11-2009
65. 20090149465 AMINOTETRALIN COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS 06-11-2009
66. 20090149454 Benzomorpholine derivatives and methods of use 06-11-2009
67. 20090148921 Compositions and methods for enhancing apoptosis 06-11-2009
68. 20090148457 HEPATOCYTE GROWTH FACTOR RECEPTOR ANTAGONISTS AND USES THEREOF 06-11-2009
69. 20090148448 METHODS AND COMPOSITIONS FOR MODULATING AND DETECTING WISP ACTIVITY 06-11-2009
70. 20090148435 ANTIBODY PURIFICATION BY CATION EXCHANGE CHROMATOGRAPHY 06-11-2009
71. 20090143386 Human adam-10 inhibitors - compounds useful for inhibiting the ADAM-10 protein 06-04-2009
72. 20090142786 SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME 06-04-2009
73. 20090142348 Novel Gene Disruptions, Compositions and Methods Relating Thereto 06-04-2009
74. 20090142259 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors 06-04-2009
75. 20090137476 Apo-2 ligand variants and uses thereof - The disclosure provides Apo-2 ligand variant polypeptides 05-28-2009
76. 20090137460 Cross-linked glycopeptide-cephalosporin antibiotics 05-28-2009
77. 20090136997 PRO1550 POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME 05-28-2009
78. 20090136492 THERAPY OF OCULAR DISORDERS - The present application describes therapy of ocular disorders using antagonists, such as antibodies, that bind to CD2 05-28-2009
79. 20090131407 TETRACYCLIC KINASE INHIBITORS - The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment 05-21-2009
80. 20090124612 Fused heterocyclic derivatives and methods of use 05-14-2009
81. 20090124609 Fused heterocyclic derivatives and methods of use 05-14-2009
82. 20090123930 METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS 05-14-2009
83. 20090111850 Amino-Substituted Ethylamino Beta2 Adrenergic Receptor Agonists 04-30-2009
84. 20090111737 Novel antibacterial agents - This invention relates to novel multibinding compounds that are antibacterial agents 04-30-2009
85. 20090099173 Pyridopyridazine compounds, compositions and methods of use 04-16-2009
86. 20090098112 NOVEL ANTIBODIES - the use of VEGF antagonists and a novel anti 04-16-2009
87. 20090093417 Dual-acting antihypertensive agents - compounds having the formula: STR00001 wherein: Ar, r, R 04-09-2009
88. 20090088453 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 04-02-2009
89. 20090087881 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same 04-02-2009
90. 20090087428 ANTI-FC-GAMMA RIIB RECEPTOR ANTIBODY AND USES THEREFOR 04-02-2009
91. 20090087426 Methods for Treatment of Allergic Asthma 04-02-2009
92. 20090083866 TRANSGENIC ROSA26-LUCIFERASE MICE FOR BIOLUMINESCENT IMAGING 03-26-2009
93. 20090082397 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 03-26-2009
94. 20090081232 METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES 03-26-2009
95. 20090081229 ANTI-PRO87299 ANTIBODIES - compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune 03-26-2009
96. 20090081223 FIXED DOSING OF HER ANTIBODIES - The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab 03-26-2009
97. 20090076026 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 03-19-2009
98. 20090075317 METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION 03-19-2009
99. 20090069534 Hydrochloride salts of a glycopeptide phosphonate derivative 03-12-2009
100. 20090069335 Guanidine-containing compounds useful as muscarinic receptor antagonists 03-12-2009
101. 20090068178 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin 03-12-2009
102. 20090068110 ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR RECEPTOR 03-12-2009
103. 20090062335 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists 03-05-2009
104. 20090062334 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists 03-05-2009
105. 20090062333 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists 03-05-2009
106. 20090062332 Disubstituted alkyl-8-azabicyclo[3.2.1] octane compounds as mu opioid receptor antagonists 03-05-2009
107. 20090062274 Pyridopyrimidinone inhibitors of pi3kalpha 03-05-2009
108. 20090054631 COMPOSITIONS AND METHODS FOR TREATMENT OF NON-HODGKIN'S LYMPHOMA 02-26-2009
109. 20090054624 PRO1190 POLYPEPTIDES - novel polypeptides having homology to CDO protein and to nucleic acid molecules encoding those polypeptides 02-26-2009
110. 20090054463 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor 02-26-2009
111. 20090054460 Piperazine derivatives and methods of use 02-26-2009
112. 20090053230 ANTI-OX40L ANTIBODIES AND METHODS USING SAME 02-26-2009
113. 20090053216 Treatment with Anti-VEGF Antibodies - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 02-26-2009
114. 20090048313 2-AMIDO-THIAZOLE-BASED COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF 02-19-2009
115. 20090048299 Biphenyl compounds useful as muscarinic receptor antagonists 02-19-2009
116. 20090048259 Phthalazine compounds, compositions and methods of use 02-19-2009
117. 20090047291 MODULATORS OF HEPATOCYTE GROWTH FACTOR ACTIVATOR 02-19-2009
118. 20090041788 Apo-2L receptor agonist and CPT-11 synergism 02-12-2009
119. 20090041749 Compositions and methods for the diagnosis and treatment of tumor 02-12-2009
120. 20090041742 HUMAN DNASE II - This invention relates to a novel human deoxyribonuclease, referred to as human DNase II 02-12-2009
121. 20090036483 QUINOLINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS 02-05-2009
122. 20090028856 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use 01-29-2009
123. 20090023934 Process for preparing an intermediate to opioid receptor antagonists 01-22-2009
124. 20090023777 Substituted 4-amino-benzylpiperidine compounds 01-22-2009
125. 20090023602 BINDING POLYPEPTIDES WITH RESTRICTED DIVERSITY SEQUENCES 01-22-2009
126. 20090023228 Dual-acting Imidazole antihypertensive agents 01-22-2009
127. 20090022713 ANTI-PRO87299 ANTIBODIES - compositions containing a novel protein and methods of using those compositions for the diagnosis and treatment of immune 01-22-2009
128. 20090018165 Biphenyl compounds useful as muscarinic receptor antagonists 01-15-2009
129. 20090018135 Methods of treating bowel disorders - methods for treating or preventing bowel disorders using calcimimetics 01-15-2009
130. 20090017559 Methods for diagnosing renal disorders - methods for diagnosing the presence and progress of pathologies characterized by an accumulation of the 01-15-2009
131. 20090017043 Connective tissues growth factor antibodies 01-15-2009
132. 20090012003 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 01-08-2009
133. 20090010925 ANTIBODY VARIANTS - of parent antibodies are disclosed which have one or more amino acids inserted in a hypervariable region of the parent antibody and 01-08-2009
134. 20090010924 Apoptotic Anti-IgE Antibodies - The present application relates to apoptotic anti-IgE antibodies nucleic acid encoding the same 01-08-2009
135. 20090010883 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 01-08-2009
136. 20090010881 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 01-08-2009
137. 20090004204 Assays and methods using biomarkers - Methods and assays examining expression of one or more biomarkers in a mammalian tissue or cell sample are 01-01-2009
138. 20090004189 BIOLOGICAL MARKERS PREDICTIVE OF RHEUMATOID ARTHRITIS RESPONSE TO B-CELL ANTAGONISTS 01-01-2009
139. 20080318989 Pyrimidine Kinase Inhibitors - The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment 12-25-2008
140. 20080318951 Dual-acting benzoimidazole antihypertensive agents 12-25-2008
141. 20080318800 METHODS AND COMPOSITIONS FOR DETECTING AUTOIMMUNE DISORDERS 12-25-2008
142. 20080317758 Polypeptide variants with altered effector function 12-25-2008
143. 20080317753 SELECTING PATIENTS FOR THERAPY WITH A HER INHIBITOR 12-25-2008
144. 20080312407 Glycopeptide phosphonate derivatives - Disclosed are glycopeptides that are substituted with one or more substituents each comprising one or more 12-18-2008
145. 20080312232 Substituted amide derivatives and methods of use 12-18-2008
146. 20080311134 CYSTEINE ENGINEERED ANTI-MUC16 ANTIBODIES AND ANTIBODY DRUG CONJUGATES 12-18-2008
147. 20080311107 Novel Gene Disruptions, Compositions and Methods Relating Thereto 12-18-2008
148. 20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same 12-11-2008
149. 20080305106 Novel Gene Disruptions, Composition and Methods Relating Thereto 12-11-2008
150. 20080299136 WNT ANTAGONISTS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF WNT-MEDIATED DISORDERS 12-04-2008
151. 20080299119 POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 12-04-2008
152. 20080299117 Treatment Method - The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies of 100 mg to 200 mg 12-04-2008
153. 20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof 12-04-2008
154. 20080299115 Antibody Variants with Faster Antigen Association Rates 12-04-2008
155. 20080293121 HUMAN DNASE I HYPERACTIVE VARIANTS - amino acid sequence variants of human DNase I that have increased DNA-hydrolytic activity 11-27-2008
156. 20080292631 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 11-27-2008
157. 20080292630 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 11-27-2008
158. 20080287486 Prokinetic agent for bowel preparation - The invention provides methods of bowel preparation before a diagnostic surgical or therapeutic procedure 11-20-2008
159. 20080286271 Methods and Compositions for Modulating Tweak and Fn14 Activity 11-20-2008
160. 20080281076 IL-6 binding proteins - Polypeptides comprising monomer domains that bind to IL-6, or portions thereof, are provided 11-13-2008
161. 20080280917 Nitrogen-Containing heterocyclyl ketones and methods of use 11-13-2008
162. 20080280856 Fibroblast Activation Protein Inhibitor Compounds and Methods 11-13-2008
163. 20080279860 Treatment With Anti-VEGF Antibodies - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 11-13-2008
164. 20080274993 Methods and compositions for modulating vascular integrity 11-06-2008
165. 20080274506 POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION 11-06-2008
166. 20080274108 POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION 11-06-2008
167. 20080274105 POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION 11-06-2008
168. 20080269344 Beta2-Adrenergic Receptor Agonists - Disclosed are multibinding compounds which are 10-30-2008
169. 20080269305 Dual-acting antihypertensive agents - The invention is directed to compounds having the formula: wherein: Ar, r, Y, Z, Q, W, X, and R 10-30-2008
170. 20080269190 Quaternary ammonium compounds useful as muscarinic receptor antagonists 10-30-2008
171. 20080267968 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-30-2008
172. 20080255187 5-HT4 RECEPTOR AGONIST COMPOUNDS - The invention provides novel quinolinone-carboxamide 5-HT 10-16-2008
173. 20080255181 Methods for treating podocyte-related disorders 10-16-2008
174. 20080254487 Connective Tissue Growth Factor Signaling 10-16-2008
175. 20080254024 ANTI-EPHB2 ANTIBODIES AND METHODS USING SAME 10-16-2008
176. 20080249106 Novel B1 bradykinin receptor antagonists 10-09-2008
177. 20080248049 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-09-2008
178. 20080248037 Dr5 Antibodies and Uses Thereof - The application provides antibodies which specifically bind to DR5 receptor 10-09-2008
179. 20080248036 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-09-2008
180. 20080247951 ANTI-ROBO4 ANTIBODIES AND USES THEREFOR - The invention provides anti-Robo4 antibodies and compositions comprising the antibodies and methods of using 10-09-2008
181. 20080242709 2-AMIDO-4-ISOXAZOLYL THIAZOLE COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF 10-02-2008
182. 20080242655 AZA-INDOLYL COMPOUNDS AND METHODS OF USE 10-02-2008
183. 20080241898 Application of Glucose Transport Mutants For Production Of Aromatic Pathway Compounds 10-02-2008
184. 20080241159 METHODS AND COMPOSITIONS FOR SELECTIVE MODULATION OF VASCULARIZATION 10-02-2008
185. 20080241148 TREATMENT WITH ANTI-VEGF ANTIBODIES - This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies 10-02-2008
186. 20080241146 Apo-2 ligand-anti-Her-2 antibody synergism 10-02-2008
187. 20080241143 Inhibition of leukocyte adhesion - This invention relates to the inhibition of intercellular adhesion mediated by L-selectin by administering a newly 10-02-2008
188. 20080234268 Bis-aryl amide derivatives and methods of use 09-25-2008
189. 20080233646 Human DR4 antibodies and uses thereof - Human Death Receptor 4 antibodies are provided 09-25-2008
190. 20080227963 Process for preparing glycopeptide phosphonate derivatives 09-18-2008
191. 20080227119 ELISA for VEGF - The vascular endothelial growth factor activity in a patient's bloodstream or other biological sample can serve as a diagnostic and 09-18-2008
192. 20080226629 ANTI-VEGF ANTIBODIES - Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed 09-18-2008
193. 20080226621 ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND TREATMENT OF NOTCH3-RELATED DISEASES 09-18-2008
194. 20080221101 Calcium receptor modulating agents - generally to compounds represented in Formula I pharmaceutical compositions comprising them and methods of treating 09-11-2008
195. 20080221014 Method of Diagnosing and Treating Glioma 09-11-2008
196. 20080220471 Vectors and Methods Using Same - vectors and to methods of using same 09-11-2008
197. 20080214544 Substituted heterocycles and methods of use 09-04-2008
198. 20080213837 Apo-3 ligand polypeptide - tumor necrosis factor and lymphotoxin homolog having apoptotic activity, identified as Apo-3 Ligand, is provided 09-04-2008
199. 20080213280 THERAPY OF AUTOIMMUNE DISEASE IN A PATIENT WITH AN INADEQUATE RESPONSE TO A TNF-ALPHA INHIBITOR 09-04-2008
200. 20080213272 VEGF-RELATED PROTEIN - human VEGF-related protein has been identified and isolated that binds to and stimulates the phosphorylation of 09-04-2008
201. 20080213268 NEUROPILIN ANTAGONISTS - Novel anti-NRP1 antibodies and variants thereof having unique structural and functional characteristics are disclosed 09-04-2008
202. 20080207736 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists 08-28-2008
203. 20080207676 Crystalline forms of an 8-Azabicyclo(3.2.1)octane compound 08-28-2008
204. 20080206256 Treatments for cancer - methods for reducing tumor survival, expansion, and metastasis 08-28-2008
205. 20080206243 Methods for Treating Kidney Disorders - Provided are methods of treating kidney disorders in a subject by administering an effective amount of VEGFR 08-28-2008
206. 20080200464 Substituted heterocycles and methods of use 08-21-2008
207. 20080200375 Angiogenesis using hepatocyte growth factor 08-21-2008
208. 20080199464 Combination Therapy with Angiogenesis Inhibitors 08-21-2008
209. 20080199423 Methods of Using Apo2l Receptor Agonists and Ink Cell Activators 08-21-2008